Monopar Therapeutics (MNPR) News Today $34.15 -1.91 (-5.30%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$33.44 -0.70 (-2.06%) As of 08/29/2025 06:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Why Is Monopar Therapeutics Dropping Today?Toggle Visibility of Why Is Monopar Therapeutics Dropping Today?Monopar Therapeutics Inc. (NASDAQ:MNPR) shares dipped today after a flurry of analyst updates but remain underpinned by bullish ratings: Positive Sentiment: Cantor Fitzgerald reissued an Overweight rating on MNPR and set a $74.00 price target.Monopar Therapeutics (NASDAQ:MNPR) Given Overweight Rating at Cantor Fitzgerald Positive Sentiment: Cantor Fitzgerald reaffirmed its Overweight rating for MNPR shares.Monopar Therapeutics' (MNPR) "Overweight" Rating Reaffirmed at Cantor Fitzgerald Positive Sentiment: HC Wainwright reiterated its Buy rating and maintained a $70.00 price objective on MNPR.Monopar Therapeutics (NASDAQ:MNPR) Given Buy Rating at HC Wainwright Neutral Sentiment: HC Wainwright released detailed EPS forecasts—covering Q3–Q4 2025 through FY 2029—that project continued losses but keep a Buy rating and $70 target on MNPR.Free Report Posted 13h agoAI Generated. May Contain Errors. MNPR Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Q3 Earnings Estimate for MNPR Issued By HC Wainwright1 hour ago | marketbeat.comAnalysts Issue Forecasts for MNPR Q3 Earnings5 hours ago | americanbankingnews.comMonopar Therapeutics (NASDAQ:MNPR) Given Overweight Rating at Cantor FitzgeraldAugust 29 at 9:25 AM | marketbeat.comMonopar Therapeutics' (MNPR) "Overweight" Rating Reaffirmed at Cantor FitzgeraldAugust 29 at 3:02 AM | americanbankingnews.comAffinity Asset Advisors LLC Buys Shares of 62,000 Monopar Therapeutics Inc. $MNPRAugust 28 at 9:09 AM | marketbeat.comMonopar Therapeutics (NASDAQ:MNPR) Given Buy Rating at HC WainwrightAugust 28 at 8:20 AM | marketbeat.comMonopar Therapeutics (NASDAQ:MNPR) Now Covered by HC WainwrightAugust 27 at 2:01 AM | americanbankingnews.comMonopar Therapeutics assumed with a Buy at H.C. WainwrightAugust 26, 2025 | msn.comMonopar Therapeutics management to meet with Cantor FitzgeraldAugust 22, 2025 | msn.comWhat is Chardan Capital's Forecast for MNPR FY2025 Earnings?August 19, 2025 | marketbeat.comMNPR FY2025 EPS Lifted by Brookline Capital ManagementAugust 17, 2025 | marketbeat.comCantor Fitzgerald Analysts Cut Earnings Estimates for MNPRAugust 17, 2025 | marketbeat.comMonopar Therapeutics (NASDAQ:MNPR) Earns Buy Rating from Chardan CapitalAugust 15, 2025 | marketbeat.comMonopar Therapeutics (NASDAQ:MNPR) Announces Earnings Results, Beats Expectations By $0.12 EPSAugust 13, 2025 | marketbeat.comMonopar Therapeutics Inc.: Monopar Therapeutics Reports Second Quarter 2025 Financial Results and Recent DevelopmentsAugust 13, 2025 | finanznachrichten.deMonopar Therapeutics Reports Increased R&D ExpensesAugust 13, 2025 | msn.comMonopar Therapeutics Inc. Reports Q2 2025 Financial Results and Progress on ALXN1840 and MNPR-101 Clinical TrialsAugust 12, 2025 | quiverquant.comQMonopar Therapeutics Reports Second Quarter 2025 Financial Results and Recent DevelopmentsAugust 12, 2025 | globenewswire.comMonopar Therapeutics Inc. (NASDAQ:MNPR) Receives Average Rating of "Moderate Buy" from AnalystsAugust 12, 2025 | marketbeat.comMonopar Therapeutics (MNPR) Projected to Post Earnings on FridayAugust 1, 2025 | marketbeat.comMonopar Therapeutics Inc. (NASDAQ:MNPR) Receives Consensus Rating of "Moderate Buy" from AnalystsJuly 18, 2025 | marketbeat.comMonopar Therapeutics Inc. (NASDAQ:MNPR) Director Sells $356,160.00 in StockJuly 17, 2025 | marketbeat.comChristopher M. Starr Sells 16,800 Shares of Monopar Therapeutics Inc. (NASDAQ:MNPR) StockJuly 17, 2025 | marketbeat.comMonopar Therapeutics Inc. (NASDAQ:MNPR) CEO Sells $672,000.00 in StockJuly 17, 2025 | marketbeat.comMonopar Therapeutics Inc. (NASDAQ:MNPR) Director Kim R. Tsuchimoto Sells 8,904 SharesJuly 17, 2025 | insidertrades.comAnalysts Set Expectations for MNPR FY2025 EarningsJuly 9, 2025 | marketbeat.comCantor Fitzgerald Initiates Coverage of Monopar Therapeutics (MNPR) with Overweight RecommendationJuly 8, 2025 | msn.comMonopar Therapeutics (NASDAQ:MNPR) Coverage Initiated by Analysts at Cantor FitzgeraldJuly 7, 2025 | marketbeat.comFY2025 Earnings Forecast for MNPR Issued By Chardan CapitalJune 29, 2025 | marketbeat.comChardan Initiates Coverage of Monopar Therapeutics (MNPR) Stock, Gives BuyJune 26, 2025 | finance.yahoo.comInstitutional investors own a significant stake of 29% in Monopar Therapeutics Inc. (NASDAQ:MNPR)June 23, 2025 | finance.yahoo.comChardan Capital Initiates Coverage of Monopar Therapeutics (MNPR) with Buy RecommendationJune 23, 2025 | msn.comMonopar Therapeutics Inc. (NASDAQ:MNPR) Given Average Recommendation of "Moderate Buy" by BrokeragesJune 23, 2025 | marketbeat.comMonopar Therapeutics (NASDAQ:MNPR) Earns Buy Rating from Analysts at Chardan CapitalJune 23, 2025 | marketbeat.comMonopar Therapeutics (NASDAQ:MNPR) Trading 0.4% Higher - Time to Buy?June 12, 2025 | marketbeat.comMonopar Therapeutics Inc.: Monopar and EDNOC Announce Expanded Access Program for MNPR-101-Zr and MNPR-101-Lu in Advanced CancersJune 11, 2025 | finanznachrichten.deMonopar and EDNOC Announce Expanded Access Program for MNPR-101-Zr and MNPR-101-Lu in Advanced CancersJune 11, 2025 | globenewswire.comMonopar Therapeutics Inc. (NASDAQ:MNPR) Short Interest Down 13.8% in MayJune 5, 2025 | marketbeat.comMonopar Therapeutics added to Russell 3000 and 2000 indexes, stock up 15%June 3, 2025 | msn.comMonopar Therapeutics Announces Inclusion in the Russell 3000® and Russell 2000® IndexesJune 3, 2025 | globenewswire.comMonopar Therapeutics (NASDAQ:MNPR) Stock Rating Upgraded by Wall Street ZenMay 24, 2025 | marketbeat.comPoint72 Asset Management L.P. Takes Position in Monopar Therapeutics Inc. (NASDAQ:MNPR)May 23, 2025 | marketbeat.comJanus Henderson Group PLC Invests $23.44 Million in Monopar Therapeutics Inc. (NASDAQ:MNPR)May 18, 2025 | marketbeat.comMonopar Therapeutics Reports First Quarter 2025 Financial Results and Recent DevelopmentsMay 13, 2025 | globenewswire.comMonopar Therapeutics Presents Long-Term Efficacy and Safety Data for ALXN1840 in Wilson Disease at EASL International Liver Congress 2025May 8, 2025 | nasdaq.comMonopar Presents ALXN1840 Late-Breaker Data at EASL 2025May 7, 2025 | globenewswire.comGeode Capital Management LLC Acquires 24,530 Shares of Monopar Therapeutics Inc. (NASDAQ:MNPR)May 4, 2025 | marketbeat.comRA Capital Management L.P. Invests $11.25 Million in Monopar Therapeutics Inc. (NASDAQ:MNPR)May 3, 2025 | marketbeat.comMonopar Therapeutics (MNPR) Projected to Post Earnings on ThursdayMay 3, 2025 | marketbeat.comAdage Capital Partners GP L.L.C. Takes Position in Monopar Therapeutics Inc. (NASDAQ:MNPR)April 30, 2025 | marketbeat.com Get Monopar Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for MNPR and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MNPR Media Mentions By Week MNPR Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MNPR News Sentiment▼0.951.05▲Average Medical News Sentiment MNPR News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MNPR Articles This Week▼213▲MNPR Articles Average Week Get the Latest News and Ratings for MNPR and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Monopar Therapeutics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Gyre Therapeutics News Dianthus Therapeutics News BGM Group News Oculis News Mind Medicine (MindMed) News Nurix Therapeutics News Tango Therapeutics News Ginkgo Bioworks News Day One Biopharmaceuticals News ProKidney News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MNPR) was last updated on 8/30/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredTrump’s national nightmare is hereAI is no longer just about chatbots — it’s becoming the backbone of the global economy. While U.S. firms push ...Porter & Company | SponsoredNew law could create $3.7 trillion tsunami.During a meeting in Washington D.C., Jeff Brown discovered a bold initiative. He calls it “President Trump’...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Monopar Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Monopar Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MNPR Stock Alerts